Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6725-6732
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6725
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6725
Group | IL-6 (ng/L) | TNF-α (pg/L) | IL-10 (ng/L) | sICAM-1 (μg/L) | LTD4 (mg/kg) | |
Control group | Before therapy | 11.78 ± 2.32 | 55.34 ± 7.40 | 26.51 ± 6.32 | 40.78 ± 7.32 | 517.94 ± 23.40 |
After treatment | 6.62 ± 1.66 | 22.76 ± 6.64 | 16.55 ± 6.11 | 32.62 ± 5.66 | 206.96 ± 19.24 | |
Observation group | Before therapy | 11.78 ± 2.32 | 55.28 ± 7.80 | 26.81 ± 4.39 | 40.93 ± 7.27 | 517.75 ± 10.44 |
After treatment | 4.62 ± 0.66 | 19.19 ± 4.74 | 13.41 ± 3.31 | 26.74 ± 3.23 | 158.37 ± 10.37 |
- Citation: Qiu C, Feng D. Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis. World J Clin Cases 2023; 11(28): 6725-6732
- URL: https://www.wjgnet.com/2307-8960/full/v11/i28/6725.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i28.6725